Wednesday, June 10, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Markets

Market: Pharma contract manufacturing to grow at 13.3% CAGR

Fiinews by Fiinews
October 20, 2022
in Markets
Reading Time: 2 mins read
A A
0
Aurobindo
0
SHARES
11
VIEWS
LinkedinShare on Twitter

Manufacturing edge: 58 companies are certified by US FDA, WHO, MCC and MHRA

The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during 2022-28, as India, being one of the free trade agreement members, holds the access to the best established and emerging pharmaceutical markets in the Asia-Pacific region.

Due to the favorable factors, such as low manufacturing cost, easy availability of skilled workers, and well-established certified plants, the Indian pharmaceutical contract manufacturing has witnessed higher growth, said the report “Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028”.

Nearly 58 companies have certification including Emcure Pharmaceuticals Ltd which is certified with US FDA, WHO, Medical Control Council (MCC) and the Medicine and Healthcare products Regulatory Authority of the United Kingdom, according to the report released on 19 Oct 2022.

In basic manufacturing of medical drugs and devices, India has a superior edge over nations, such as Vietnam, China and Ireland, owing to the availability of immense raw material, technical workforce and WHO-approved production premises.

During the COVID-19 pandemic, several initiatives were taken by the Union Cabinet to boost the Indian pharmaceutical industry, which includes the amendment of the existing foreign direct investment (FDI), which allows the foreign investors to invest up to 100% under the automatic route for manufacturing medical devices.

With the advent of global pharmaceutical organizations, and their vast presence in India, the concept of contract manufacturing has steadily evolved, which in turn boosts the growth of India’s pharmaceutical contract manufacturing market, said the report.

Leading companies in the sector are:

Agrata Biotech Ltd

Ankur Drugs and Pharma Ltd

Aurobindo Pharma

BDR Pharmaceuticals Internationals Pvt Ltd

Ceegolabs Pvt Ltd

Ciron Drugs & Pharmaceuticals Pvt Ltd

Contract Pharmaceuticals Ltd

Cosway Biosciences

Cubic Lifesciences Pvt Ltd

Daffohils Laboratories Pvt Ltd. fiinews.com

Tags: ResearchAndMarkets
ShareTweetShare

Related Posts

Naresh ahuja
Markets

Market: Indian retail sector grows at 10 percent

by Fiinews
June 9, 2026
0
18

Singapore’s ETP expands in India and Asia Pacific The Indian retail sector is expected to grow at over 10 per...

Komatsu
Markets

Market: Komatsu-SMFG scheme to support customers

by Fiinews
June 6, 2026
0
19

Narayanan committed to empowering aspirations through accessible financial solutions Komatsu India Private Limited (KIPL) and SMFG India Credit Co Ltd...

Bharat Petroleum

Market: BPCL grows in key energy sector

June 5, 2026
15
Tata Steel

Market: Steel industry sustains growth trajectory

June 6, 2026
12
NPCI

Market: NPCI launches UPI in Cambodia

June 5, 2026
13
Xevyte

Market: Xevyte Poland serves global enterprises

June 4, 2026
14
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Investment: India welcomes US investment and technology collaboration

    0 shares
    Share 0 Tweet 0
  • Market: PM Modi-President Zelenskyy discussed trade and technology

    0 shares
    Share 0 Tweet 0
  • Manufacturing: Approved ‘BioE3’of Biotechnology Dept

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Project: Jamnagar to support RIL-Meta globally
  • Tender: Rs.1,234.91cr Amaravati GPRA approved
  • Tender: Phase 2(A) of Ahmedabad Metro approved
  • Project: Afcons builds breakwater for Vadhvan Port
  • Invest: Madhya Pradesh facility for Haleon market

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.